The Latest Breaking News from Vaccine

There have now been 79 laboratory confirmed cases of monkeypox in Scotland, and there is a reported 'limited global supply' of the smallpox vaccine to protect against the disease.

Public Health Scotland (PHS) said there have now been 79 laboratory confirmed cases of monkeypox in Scotland, and there is a reported 'limited global supply' of the smallpox vaccine to protect against the disease.

"Comments such as this are not just hurtful, they are also deeply unhelpful."

Rates of new cases are declining in major cities, suggesting public health campaigns are working.

The U.S. Food and Drug Administration (FDA) has approved Incyte’s (NASDAQ:INCY) Pemazyre (pemigatinib), a selective fibroblast growth factor receptor (FGFR) inhibitor, for the treatment of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with FGFR1 rearrangement. Incyte shares traded in a range of $71.38 to $72.98 on day volume of 1.25…

Federal health officials expressed cautious optimism Friday about the trajectory and spread of the monkeypox outbreak, emphasizing that increased vaccination, harm reduction behaviors and educational and outreach efforts appear to be helping to curb the spread.

Today’s warning comes after recent data from the Health Protection Surveillance Centre showed a "worrying drop in the uptake of childhood vaccines in two-year-olds"

The Biden administration says it has shipped enough monkeypox vaccine to deliver the first of two doses to all of the 1.6 million people identified to be at highest risk of infection from the virus

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech US-listed shares were down about 1.5%…